ClinicalTrials.Veeva

Menu

Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone

Novartis logo

Novartis

Status and phase

Completed
Phase 3

Conditions

Dyslipidemia

Treatments

Drug: fluvastatin, ezetimibe

Study type

Interventional

Funder types

Industry

Identifiers

NCT00171288
CXUO320BES03

Details and patient eligibility

About

The objective of this study is to assess the effect of the combination treatment on C-reactive protein and inflammatory markers as well as the safety and tolerability in a Spanish population

Enrollment

83 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 18-75 Primary hypercholesterolemia Signed informed consent

Exclusion criteria

  • Patients involved in clinical trials 3 months prior to inclusion Patients treated with drugs specified in protocol Fertile women not using contraceptive methods

Other protocol defined in and exclusion criteria may apply

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems